metricas

Annals of Hepatology

Suggestions
Annals of Hepatology Most often read
Journal Information

Most often read

993506
Skin manifestations of liver diseases
A. Koulaouzidis;, S. Bhat;, J. Moschos
Ann Hepatol. 2007;6:181-4
993506
Open access
135224
COVID-19 and the liver: What do we know after six months of the pandemic?
Nora A. Fierro
Ann Hepatol. 2020;19:590-1
135224
Open access
Open Article
101587
Effects of systemic chemotherapy on the liver
Giuliano Ramadori, Silke Cameron
Ann Hepatol. 2010;9:133-43
101587
Open access
88527
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
88527
Full text access
79751
Bile Acid Physiology
Agostino Di Ciaula, Gabriella Garruti, Raquel Lunardi Baccetto, Emilio Molina-Molina, Leonilde Bonfrate, David Q.-H. Wang, Piero Portincasa
Ann Hepatol. 2017;16 Supl 1:S4-S14
79751
Open access
66353
Diagnosis of liver nodules within and outside screening programs
Massimo Colombo
Ann Hepatol. 2015;14:304-9
66353
Open access
60611
Patterns of viral load in chronic hepatitis B patients in Brazil and their association with ALT levels and HBeAg status
Marcelo Eidi Nita, Nelson Gaburo, Hugo Cheinquer, Gilbert L’ltalien, Evaldo Stanislau Affonso de Araujo, Patricia Mantilla, Nancy Cure-Bolt, Paulo A. Lotufo
Ann Hepatol. 2009;8:339-45
60611
Open access
53089
Current concepts in alcohol metabolism
Juan Caballería
Ann Hepatol. 2003;2:60-8
53089
Open access
49017
Treatment of hyperferritinemia
Melanie D. Beaton, Paul C. Adams
Ann Hepatol. 2012;11:294-300
49017
Open access
46966
Transmission routes of hepatitis C virus infection
Eduardo Zumaeta Villena
Ann Hepatol. 2006;5 Supl 1:S12-4
46966
Open access
46112
Shark liver oil: hidden dangers
Serta Kilincalp, Murat Deveci, Omer Basar, Fuat Ekiz, Sahin Coban, Osman Yuksel
Ann Hepatol. 2012;11:728-30
46112
Open access
43806
The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies
Umar Hayat, Ali A. Siddiqui, Hayrettin Okut, Saba Afroz, Syed Tasleem, Ahmed Haris
Ann Hepatol. 2021;20C:100254
43806
Open access
43798
Guidelines for the diagnosis and treatment of extrahepatic portal vein obstruction (EHPVO) in children
Judith Flores-Calderón, Segundo Morán-Villota, Solange-Heller Rouassant, Jesús Nares-Cisneros, Flora Zárate-Mondragón, Beatriz González-Ortiz, José Antonio Chávez-Barrera, Rodrigo Vázquez-Frías, ... Gustavo Varela-Fascinetto
Ann Hepatol. 2013;12 Supl 1:S3-S24
43798
Open access
42263
Current concepts in acute liver failure
Maximiliano Rovegno, Magdalena Vera, Alex Ruiz, Carlos Benítez
Ann Hepatol. 2019;18:543-52
42263
Open access
42014
Ocular manifestations of liver disease in children: Clinical aspects and implications
Durga Prasad, Arpita Bhriguvanshi
Ann Hepatol. 2020;19:608-13
42014
Open access
41125
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
Helen H. Wang, Gabriella Garruti, Min Liu, Piero Portincasa, David Q.-H. Wang
Ann Hepatol. 2017;16 Supl 1:S27-42
41125
Open access
41083
Beta blockers in portal hypertension. Are they really a good option?
Eric López-Méndez, Misael Uribe
Ann Hepatol. 2006;5:86-91
41083
Open access
40458
Silymarin is an ally against insulin resistance: A review
Karla MacDonald-Ramos, Layla Michán, Alejandra Martínez-Ibarra, Marco Cerbón
Ann Hepatol. 2021;23C:100255
40458
Open access
40365
Hepatic Hydrothorax
Yong Lv, Guohong Han, Daiming Fan
Ann Hepatol. 2018;17:33-46
40365
Open access
39793
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, ... Mario G. Pessoa
Ann Hepatol. 2025;30:101903
39793
Full text access
Article options
Tools